Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Becton, Dickinson and Company    BDX

BECTON, DICKINSON AND COMPANY

(BDX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Becton Dickinson and : Swung to Profit in 4Q

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/05/2019 | 06:49am EST

By Kim Richters

Becton, Dickinson and Co. (BDX) on Tuesday said it swung to a profit in the fourth quarter of its fiscal year on higher revenue.

The New Jersey-based medical-technology company earned a quarterly profit of $150 million, or 41 cents a share, compared with a loss of $135 million, or 64 cents a share, for the same period last year.

On adjusted basis, the company reported a profit of $3.31 a share for the quarter, compared with $2.93 last year and analysts' forecasts of $3.30, according to FactSet.

Revenue rose to $4.58 billion from $4.04 billion for the quarter, while revenue for its fiscal year ending Sept. 30 increased 8.2% to $17.30 billion.

For the next fiscal year, the company expects revenue to increase 4-4.5% and adjusted profit per share to increase 9.5-11% to between $12.50 and $12.65.

Write to Kim Richters at kim.richters@wsj.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BECTON, DICKINSON AND COMP
01/23BECTON DICKINSON AND : BD Announces Webcast of Annual Meeting of Shareholders
PR
01/17Health Executives Brace for Change In Regulation and Competition -- WSJ
DJ
01/16Health Executives Gear Up for Change at J.P. Morgan Conference
DJ
01/10BECTON DICKINSON AND : LongueVue Capital Adds Experienced Healthcare Operating P..
PR
01/09BECTON DICKINSON AND : BD Announces Live Webcast Of First Fiscal Quarter Earning..
PR
01/06BECTON, DICKINSON AND COMPANY : Report
CO
01/03BECTON DICKINSON AND : BD to Present at the 38th Annual J.P. Morgan Healthcare C..
PR
01/03BECTON, DICKINSON AND COMPANY : Report
CO
2019BECTON, DICKINSON AND COMPANY : Report
CO
2019BECTON, DICKINSON AND COMPANY : Report
CO
More news
Financials (USD)
Sales 2020 18 038 M
EBIT 2020 4 805 M
Net income 2020 2 435 M
Debt 2020 15 093 M
Yield 2020 1,27%
P/E ratio 2020 28,1x
P/E ratio 2021 24,1x
EV / Sales2020 5,02x
EV / Sales2021 4,64x
Capitalization 75 539 M
Chart BECTON, DICKINSON AND COMPANY
Duration : Period :
Becton, Dickinson and Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BECTON, DICKINSON AND COMP
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Average target price 286,18  $
Last Close Price 278,73  $
Spread / Highest target 13,0%
Spread / Average Target 2,67%
Spread / Lowest Target -8,51%
EPS Revisions
Managers
NameTitle
Vincent A. Forlenza Chairman & Chief Executive Officer
Thomas E. Polen President & Chief Operating Officer
Christopher R. Reidy Chief Financial Officer, CAO & EVP-Administration
John A. DeFord Chief Technology Officer & Executive VP
William R. Sigmund Chief Medical Officer & EVP
Sector and Competitors